"breast cancer treatment" trang 3 - tải miễn phí từ tailieuXANH
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
8    75    1
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016

Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016
12    32    1
Unmet needs and related factors of Korean breast cancer survivors: A multicenter, cross-sectional study

Unmet needs and related factors of Korean breast cancer survivors: A multicenter, cross-sectional study
16    60    0
Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: A study protocol

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: A study protocol
9    54    0
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
7    69    0
Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry

Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry
8    73    1
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: Use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

Early prediction of pathologic response to neoadjuvant treatment of breast cancer: Use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume
11    42    0
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: Prognostic and therapeutic implications

Cancer testis antigens and NY-BR-1 expression in primary breast cancer: Prognostic and therapeutic implications
10    75    0
Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens

Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens
10    48    1
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study
9    44    0
Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States

Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
12    88    0
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities

Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities
9    78    0
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: Retrospective analysis from Leeds Cancer Centre

Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: Retrospective analysis from Leeds Cancer Centre
12    71    0
Vertebral fractures among breast cancer survivors in China: A cross-sectional study of prevalence and health services gaps

Vertebral fractures among breast cancer survivors in China: A cross-sectional study of prevalence and health services gaps
9    74    0
Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancerrelated fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design

Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancerrelated fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design
13    48    0
Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs

Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs
9    78    0
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
13    72    0
Locally ablative treatment of breast cancer liver metastases: Identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Locally ablative treatment of breast cancer liver metastases: Identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
12    64    0
Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: A crosssectional study

Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: A crosssectional study
8    203    1
Characterization of crilin and nanocurcumin’s synergistic effect on treatment for 7.12 dimethylbenz[a]anthracene (DMBA) induced breast cancer mice

Characterization of crilin and nanocurcumin’s synergistic effect on treatment for 7.12 dimethylbenz[a]anthracene (DMBA) induced breast cancer mice
13    113    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.